Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 10
2005 1
2006 9
2007 4
2008 6
2009 8
2010 3
2011 6
2012 5
2013 10
2014 14
2015 15
2016 8
2017 5
2018 4
2019 3
2020 11
2021 7
2022 5
2023 15
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
BNCT for primary synovial sarcoma.
Fujimoto T, Suzuki M, Kuratsu S, Fujita I, Morishita M, Sudo T, Sakuma T, Nakamatsu Y, Sakurai Y, Takata T, Tamari Y, Tanaka H, Masunaga SI, Kinashi Y, Kondo N, Sakakibara S, Igaki H, Andoh T, Sakamoto S, Kawamoto T, Watabe T, Hara H, Fukase N, Kawakami Y, Matsumoto T, Akisue T, Ono K, Ichikawa H, Kuroda R, Hirose T. Fujimoto T, et al. Among authors: sakurai y. Appl Radiat Isot. 2021 Mar;169:109407. doi: 10.1016/j.apradiso.2020.109407. Epub 2020 Dec 29. Appl Radiat Isot. 2021. PMID: 33444907
Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.
Tsurubuchi T, Shirakawa M, Kurosawa W, Matsumoto K, Ubagai R, Umishio H, Suga Y, Yamazaki J, Arakawa A, Maruyama Y, Seki T, Shibui Y, Yoshida F, Zaboronok A, Suzuki M, Sakurai Y, Tanaka H, Nakai K, Ishikawa E, Matsumura A. Tsurubuchi T, et al. Among authors: sakurai y. Cells. 2020 May 21;9(5):1277. doi: 10.3390/cells9051277. Cells. 2020. PMID: 32455737 Free PMC article.
Phospholipid-Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy.
Kawasaki R, Hirano H, Yamana K, Oshige A, Nishimura K, Kono N, Sanada Y, Bando K, Tabata A, Yasukawa N, Azuma H, Takata T, Sakurai Y, Tanaka H, Suzuki M, Tarutani N, Katagiri K, Nagasaki T, Ikeda A. Kawasaki R, et al. Among authors: sakurai y. Chembiochem. 2023 Aug 1;24(15):e202300186. doi: 10.1002/cbic.202300186. Epub 2023 Jul 4. Chembiochem. 2023. PMID: 37069129
Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.
Kawasaki R, Hirano H, Yamana K, Isozaki H, Kawamura S, Sanada Y, Bando K, Tabata A, Yoshikawa K, Azuma H, Takata T, Tanaka H, Sakurai Y, Suzuki M, Tarutani N, Katagiri K, Sawada SI, Sasaki Y, Akiyoshi K, Nagasaki T, Ikeda A. Kawasaki R, et al. Among authors: sakurai y. Nanomedicine. 2023 Apr;49:102659. doi: 10.1016/j.nano.2023.102659. Epub 2023 Feb 21. Nanomedicine. 2023. PMID: 36822335
HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex.
Yamana K, Kawasaki R, Kondo K, Hirano H, Kawamura S, Sanada Y, Bando K, Tabata A, Azuma H, Takata T, Sakurai Y, Tanaka H, Kodama T, Kawamoto S, Nagasaki T, Ikeda A. Yamana K, et al. Among authors: sakurai y. Nanoscale Adv. 2023 Jun 1;5(15):3857-3861. doi: 10.1039/d3na00028a. eCollection 2023 Jul 25. Nanoscale Adv. 2023. PMID: 37496630 Free PMC article.
139 results